Summary

How MNT maps according to Revere

Sector Level Count
Industries 3
Sectors 4
Subsectors 6
Product/Service Groups 12

Specific product example for MNT

Product Hierarchy
Consumer
Consumer Products and Services
Personal Care and Cleaning Products
Skin Care

Company Highlights:

Market Cap. 1,047.455
Current Shares Outstnd. 33.8
Contact Name Loren L. McFarland
Contact Phone (805)8796000
City, State Santa Barbara, CA
Dividends Per Common Share 0.20
Dividend Yield 0.00
SI %SHOUT 7.79
IH % Shares Outst. n/a
Number of Employees 1,190
Revenue Per Employee 284,773.5
Book Value Per Share 4.43
5 Year CAGR in Revenues % -0.48
5 Year CAGR in Earnings % 3.99
Asset Turnover 0.19
Fiscal Year End 03/31/2009
Next Reporting Period Dec, 2008

Business Description:

Mentor Corporation (Mentor) develops, manufactures, licenses and markets a range of products serving the aesthetic medical market, including plastic and reconstructive surgery. The Company?s products include breast implants for plastic and reconstructive surgery, capital equipment and consumables used for soft tissue aspiration for body contouring (liposuction), and facial rejuvenation products, including various types of products for skin restoration. The Company operates in one business segment, aesthetic products. Mentor?s aesthetic products fall into three general categories: breast aesthetics, body contouring and other aesthetics, which includes facial aesthetics products. The Company develops, produces and markets a line of breast implants, including saline-filled implants and silicone gel-filled (MemoryGel and Contour Profile brand) implants.

Chart:

Last Price 31.01
Price Chg. 0.00
Price Chg. % 0.00%
Open Price 31.00
High Price 31.01
Low Price 30.99
52w High Price 35.92
52w Low Price 1.00
Volume 491,365
30d Avg. Volume 1,409,548
MNT - Chart
* Quotes delayed 20 minutes.

Products

Products Manufactured/Services Performed Details
Consumer
Consumer Products and Services
Personal Care and Cleaning Products
Skin Care

Products:

  • NIA24
Healthcare
Biopharmaceuticals
Dermatology
Aging Disorders
Wrinkles
Acetylcholine Inhibitors

Products:

  • PurTox (Botulinum Toxin Type A)
Neurology
Phase I/Phase II Clinical Stage Products

Products:

  • PurTox (Botulinum Toxin Type A)
Medical Devices
Obstetrics/Gynecology
Surgical
Region Specific
Pelvic Floor Reconstruction

Products:

  • NovaSilk Synthetic Mesh
Plastic/Reconstructive Surgery
Surgical
Procedure/Region Specific
Implants
Breast
Augmentation/Reconstructive
Saline

Products:

  • Spectrum Postoperatively Adjustable Breast Implants Series
  • Round/Shaped Saline-Filled Breast Implants
  • Contour Profile Tissue Expander (CPX) Series
Silicone

Products:

  • MemoryGel Silicone Gel Breast Implant Series
  • Perthese Silicone Breast Implant
  • Contour Profile Gel Silicone Breast Implant
Tissue Expanders

Products:

  • Smooth Tissue Expander Family
Liposuction/Lipolysis

Products:

  • Mentor UltraSculpt
Skin Grafts
Artificial Skin
Acellular

Products:

  • NeoForm Dermis
Treatment
Post Surgical Treatment
Compression

Products:

  • Caromed Post Surgery Garments
Wrinkle Removal
Hyaluronic Acid

Products:

  • dermal gel extra (DGE) Next Generation Hyaluronic Acid Dermal Filler
  • Puragen (Double Crosslinked Hyaluronic Acid Dermal Filler)
  • Prevelle Silk (Single Crosslinked Hyaluronic Acid Dermal Filler/Lidocaine)
  • Puragen Plus (Double Crosslinked Hyaluronic Acid Dermal Filler)
Technology
Software
Industry-Specific
Healthcare/Pharma
Business Management/Information Systems
Practice/Clinic Management
Cosmetic

Products:

  • Mentor Solutions Inform&Consent
  • Mentor Solutions Inform&Enhance
  • Mentor Solutions MDTracker
  • Mentor Solutions InSched

Key Financials

FY Ends September
Period Length/End 3 months
ending
09/26/2008 		3 months
ending
06/27/2008 		3 months
ending
09/30/2007 		12 months
ending
03/31/2008 		12 months
ending
03/31/2007 		12 months
ending
03/31/2006
Total Revenue 84.5 105.5 85.4 373.2 302.0 268.3
Gross Margin % 69.68 72.15 70.16 73.47 73.95 74.2
Operating Income 10.0 22.2 14.3 79.1 65.6 69.1
Operating Margin % 11.8 21.03 16.76 21.19 21.73 25.74
Tax Rate % 5.18 29.26 26.05 29.84 29.87 28.97
Income After Taxes 10.1 15.1 10.0 55.0 57.6 48.1
Net Income Margin % 12 14.31 11.74 14.72 19.08 17.92
F.D. EPS - Incl. Xord. Items 0.27 0.40 0.26 1.61 5.99 1.29
Book Value Per Share 4.43 4.58 3.37 4.24 10.26 5.25

Ratios

P/R Ratio (TTM) 2.74
P/E Ratio (TTM) 18.61
Price To Free Cash Flow (TTM) 72.50
Price To Book Value 6.01
Net Assets to Market Cap. % 34.24%
Beta 1.43
Days to Sell Inventory 184.77
Current Ratio 2.48
Quick Ratio 1.53
Interest Coverage n/a
Debt to Market Cap. % 14.39%
Return on Equity % 32.34
Return on Assets % 10.95
Return on Invested Capital % 16.85

Major Competitors

Name Trailing Revenue P/R Ratio (TTM) P/E Ratio (TTM) 1 Year Return % Overlap
Allergan, Inc. 4,437.4 2.58 19.49 -41.96% 6
Average 4,437.4 2.58 19.49 -41.96% 6

Notes:

Customers

Name Last Quarter Financial Stats 1 YR Price Performance %
Y/Y Revenue Growth % Sequential Revenue Growth % Y/Y Margin Growth % Sequential Margin Growth %
Government - United States n/a n/a n/a n/a n/a
Average n/a n/a n/a n/a n/a

Notes:

Strategic Partners

Name Subtypes 1 YR Price Performance %
Coloplast Corp. Supplier n/a
Genzyme Corporation Research Collaboration -11.33%
Le Mystere Marketing n/a
Niadyne, Inc. Supplier n/a
Rochester Medical Corporation In-licensing, Supplier 6.77%

Business/Geographical Segments

Business Segments

Source:  10-K Jun 14, 2006
  External Revenue Total Revenue
Aesthetic and General Surgery 72.4 54.2% 72.4 54.2%
Surgical Urology 34.4 25.8% 34.4 25.8%
Clinical and Consumer Healthcare 26.8 20.0% 26.8 20.0%
Segment Total 133.6 100.0% 133.6 100.0%
Consolidated Total 133.6   133.6